Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: TD, re shareholder meeting...

Feb 26, 2007 04:54AM

Shareholders won't be too disgruntled if we still don't know the results of the Markman?  Having the SHM before Markman assures that worst case is we don't know.  Best case is we have settled.  Astute planning imo.

Share
New Message
Please login to post a reply